Projektportfölj

Portfolio

Accelerator Nordic AB holds an active majority position in a number of companies active in the Life Science space.

The Accelerator Group addresses biotechnology, pharmaceutical drug development and medical technology in large growth markets such as medical imaging, oncology and drug delivery for orthopedic and dental implants.

Portfolio

aktuell_handelse_tmp
Aktuell händelse

Press & News

21 December, 2011

Accelerator: SyntheticMR recruits Stefan Tell as CEO

SyntheticMR AB, a subsidiary of Accelerator Nordic AB, has recruited Stefan Tell as CEO.

Full post

The Stock

  • Buy:  
  • Ask:  
  • Latest:  

Press releases

21 December, 2011

Accelerator: SyntheticMR recruits Stefan Tell as CEO

12 December, 2011

Dr. Anders Jönsson appointed to AddBIO’s advisory board

30 November, 2011

Accelerator: SPAGO Imaging granted financing from VINNOVA


Calendar

Feb 24, 2012

Quarterly report Jan-Dec 2011

Apr 25, 2012

Annual general meeting

Apr 25, 2012

Quarterly report Jan-Mar 2012

 

Twitter

 

 

 

Company Presentation

Watch the latest presentation of Accelerator by CEO Andreas Bunge


Presentations

Logo Optovent Logo Spago Logo AddBIO Logo Synthetic MR Logo OptoQ AB